Beth Israel Deaconess Medical Center: Parkinson Disease trials

The registry lists 11 Parkinson Disease studies with Beth Israel Deaconess Medical Center as lead sponsor. 1 are open to participants now and 3 have results posted.

Phase 2 2Phase 4 1No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Gastrointestinal Dopamine Decarboxylase and Levodopa PharmacokineticsNot yet recruitingNCT07793461Phase 4
• Incobotulinum Toxin A (Xeomin®) for Troublesome Sialorrhea in Parkinson's Disease (PD)/ParkinsonismCompletedNCT01653132Phase 2Results posted
• rTMS for Motor and Mood Symptoms of Parkinson's DiseaseCompletedNCT01080794Not applicableResults posted
• Laser Light Cues for Gait Freezing in Parkinson's DiseaseCompletedNCT00320242Not applicableResults posted
• Yoga for Mental Health in Parkinson's PatientsCompletedNCT05335850Not applicable
• Gait Analysis in Neurological DiseaseActive, not recruitingNCT02994719
• Non-invasive Measurement of Brain Oxygen Levels in People With Subthalamic Deep Brain StimulatorsCompletedNCT02278406Not applicable
• Innovative Measures of Speech and Swallowing Dysfunction in Neurological DisordersCompletedNCT02118805
• Incobotulinum Toxin A for Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS)WithdrawnNCT01565395Phase 2
• Dance Exercise as Novel Complementary Therapy for Parkinson's DiseaseCompletedNCT01163344
• Singing in Groups for Parkinson's Disease; A Pilot Study of Group Singing Therapy for PD-related Voice/Speech ImpairmentCompletedNCT01163331Not applicable